Scientists Found Cancer in a Dinosaur – And It Might Help Save Human Lives
But a new study suggests that soft tissue preserved for millions of years inside ancient bones could offer valuable insights into how cancer works – and how we might treat it today.
Researchers from the UK and Romania examined the fossilized remains of a Telmatosaurus transsylvanicus dinosaur, a small, cow-sized 'marsh lizard' that lived around 66–70 million years ago in what is now Romania.
Using high-powered microscopy, the team discovered structures resembling red blood cells (or erythrocytes), linked to a tumor in the dinosaur's jaw, which a previous study discovered.
It's a discovery that suggests small flecks of soft tissue may be preserved in fossils more often than we thought – and that means there's much more we can figure out about these ancient creatures, including any diseases they had.
"Unlike skeletal structures alone, soft tissues contain proteins that provide molecular information that can reveal the underlying biological mechanisms of disease," says oncologist Justin Stebbing, from Anglia Ruskin University in the UK.
"Our research, using relatively underused methods, invites further exploration that could hold the key to future discoveries that could benefit humans."
For example, finding fragments of soft dinosaur tissue like those described here could prove to be crucial in understanding cancer mechanisms and how they've evolved, the researchers suggest.
Large animals like whales and elephants have evolved ways of protecting themselves against cancer, and it's possible that dinosaurs could have, too.
Understanding these ancient biological adaptations might one day inform new approaches to cancer prevention or treatment in humans.
Careful preservation of these samples is key, however: we can assume that future scientific advances will be made in analysis equipment, but those upgrades won't be as significant without any dinosaur tissue to study.
"Dinosaurs, as long-lived, large-bodied organisms, present a compelling case for investigating how species managed cancer susceptibility and resistance over millions of years," says Stebbing.
"It is crucial that long-term fossil conservation efforts are coordinated to ensure that future researchers have access to specimens suitable for cutting-edge molecular investigations."
The dinosaur that was the focus of this study had an ameloblastoma tumor, a tumor type still found in humans today.
That the dinosaurs roamed Earth for millions of years means the potential is there to see how cancer may have changed over that time – and how the afflicted species may have adapted.
And while it may seem implausible that anything organic could survive for so long, it is possible – as this new study shows – so we can see how genetics, biology, and environmental pressures helped to cause cancer in the Late Cretaceous.
"Proteins, particularly those found in calcified tissues like bone, are more stable than DNA and are less susceptible to degradation and contamination," says Stebbing.
"This makes them ideal candidates for studying ancient diseases, including cancer, in paleontological specimens."
The research has been published in Biology.
Here's Why Rational People Skip Vaccines Even When They Trust Science
Softgel Capsules Draw Concerns Over Toxic Shells. Here's What to Know.
Your Breathing Pattern Is as Unique as a Fingerprint, Study Finds

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 days ago
- Yahoo
What to know about game-changing new weight-loss pill that could be prescribed on the NHS
Is it more or less effective than weight-loss jabs? A new study found the pill could help shed 12% of body weight. A daily pill that could help people lose a significant amount of weight – without injections – has shown promising early results in a major trial. The drug, called orforglipron, works in a similar way to known weight-loss jabs like Wegovy and Mounjaro, targeting hormones that regulate appetite and digestion. But instead of a weekly injection, it's taken daily in tablet form. In a study of more than 3,000 adults, those on the highest dose lost an average of 12.4% of their body weight over 72 weeks (almost 17 months) – that's nearly two stone for some. The trial also reported improvements in cholesterol, blood pressure and heart health, according to the study. Manufacturer Eli Lilly, the American pharmaceutical company which also created Mounjaro, says it plans to seek regulatory approval by the end of the year. Experts are cautiously optimistic, but stress the results are still preliminary and not yet peer reviewed. Here's what we know about the weight-loss pill so far. How does the weight-loss pill compare to injections? In head-to-head comparisons, injectables still lead on weight loss. Trials show Mounjaro users lose around 20% of their body weight, and Wegovy users about 13–14%. orforglipron's 12.4% average is slightly lower – but experts say its convenience could make it appealing. Kenneth Custer, the president of Eli Lilly, said: "With orforglipron, we're working to transform obesity care by introducing a potential once-daily oral therapy that could support early intervention and long-term disease management, while offering a convenient alternative to injectable treatments." In the trial, nearly 60% of people on the top dose lost at least 10% of their body weight, and almost 40% lost 15% or more. What about side effects? The safety profile looks similar to other GLP-1 or weight-loss drugs, like Wegovy and Mounjaro. In the trial, the most common side effects – of which some participants reported more than one – were stomach-related: Nausea: 33.7% Constipation: 25.4% Diarrhoea: 23.1% Vomiting: 24.0% Indigestion: 14.1% Most side effects were mild to moderate, but they were enough to make some people stop treatment. Around one in 10 people on the top dose dropped out because of side effects, compared to about one in forty in the placebo group, those given a dummy pill with no active medicine. "These are preliminary, non-peer-reviewed results and we will need to see the full trial methodology and data before a more comprehensive analysis can be undertaken," Dr Simon Cork, senior lecturer in physiology at Anglia Ruskin University told The Times. "It should be noted that their effects on weight loss are not as profound as those seen in injectable GLP-1 receptor agonists, such as Wegovy, with a lower percentage weight loss and fewer people achieving 10 per cent weight loss at the highest dose. "Nevertheless, that this medication is an oral form, rather than injectable, will likely be seen as more tolerable for many patients," he added. Who could get the weight-loss pill on the NHS? If approved, orforglipron would likely be prescribed under similar rules to existing weight-loss drugs. Currently, Wegovy is offered to people with a BMI of at least 35 plus a weight-related condition, or a BMI of 30–34.9 if referred to specialist services. Mounjaro is approved for those with a BMI over 30, or 27–30 with health issues such as pre-diabetes or high blood pressure. Any rollout would almost certainly involve combining the pill with the recommended reduced-calorie diet and more physical activity, just like the current injections. How much will the weight-loss pills cost? There's no official price tag yet for orforglipron. Eli Lilly hasn't confirmed how much it will sell for if approved, but experts expect it to be cheaper to manufacture than injections like Wegovy or Mounjaro. That could mean a lower cost for the NHS, and potentially make it more accessible for patients if offered privately. Read more about weight loss: Who can get new weight-loss jab Mounjaro on the NHS? (Yahoo Life UK, 4-min read) Alison Hammond reveals why she is 'frightened' of weight loss medications (Yahoo Life UK, 3-min read) Obesity rates may start falling this year due to weight loss jabs, seller says (Sky News, 4-min read)


USA Today
11-07-2025
- USA Today
Denver museum discovers nearly 70-million-year-old fossil under parking lot
A museum in Denver has found a fossil that is almost 70 million years old under its parking lot while running an unrelated drilling project. "This may be the most unusual dinosaur discovery I have ever been a part of," said Patrick O'Connor, director of Earth & Space Sciences at the Museum, in a statement. In January, the museum conducted a geothermal test drilling project to see if it was possible to switch from natural gas to geothermal energy, according to a press release published on the museum's website. "At that time, the team took the opportunity to carry out a scientific coring research initiative to help researchers better understand the geology of the Denver Basin," the press release stated. "The coring investigation led to the unexpected discovery of a nearly [70 million-year-old] dinosaur fossil." The discovery, a partial-bone fossil that was identified as a vertebra of a herbivorous dinosaur, is on display in the 'Discovering Teen Rex' exhibition on the museum floor. 'In my 35 years at the Museum, we've never had an opportunity quite like this — to study the deep geologic layers beneath our feet with such precision," Bob Raynolds, a longtime Earth Sciences Research Associate, said in a statement. "That this fossil turned up here, in City Park, is nothing short of magical.' More news: Pterosaur fossil discovered in Arizona's Petrified Forest National Park fills gap in record Where was the fossil located? The fossil was found 763 feet below the surface of the museum's parking lot near the city's largest park, City Park, which also contains the Denver Zoo. It "has been identified as the deepest and oldest dinosaur fossil ever found within the city limits," according to the museum. What did the fossil belong to? The museum only states that the fossil likely belonged to a plant-eating dinosaur that walked on two legs. But, it looks very similar to one belonging to a Thescelosaurus from the latest Cretaceous Period. Remains of the dinosaur have been found in Canada and the U.S., according to the Natural History Museum in London. The dinosaur, which name means "wonderful lizard," would have been nearly as tall as the average man and been around 10-12 feet long, or 3.5 meters. How old was the fossil? The bones were found in rock from the Late Cretaceous period, and are dated to be around 67.5 million years ago. 'This fossil comes from an era just before the mass extinction that wiped out the dinosaurs, and it offers a rare window into the ecosystem that once existed right beneath modern-day Denver," James Hagadorn, curator of geology at the Museum, said in a statement. It was a small ornithopod, which means a bipedal dinosaur with only three functional toes, according to Mirriam-Webster. Julia is a trending reporter for USA TODAY. Connect with her on LinkedIn, X, Instagram and TikTok: @juliamariegz, or email her at jgomez@


The Hill
11-07-2025
- The Hill
Denver dinosaur museum makes ‘historically thrilling' discovery under its own parking lot
DENVER (KDVR) — The Denver Museum of Nature and Science (DMNS) announced on Wednesday that it had discovered a nearly 70-million-year-old dinosaur fossil underneath its parking lot. The partial-bone fossil was found 763 feet below the lot during a geothermal test drilling project in January, according to the museum. 'This is a scientifically and historically thrilling find for both the Museum and the larger Denver community,' said James Hagadorn, the curator of geology at the DMNS, in a statement. The museum said the fossil is the deepest and oldest dinosaur fossil ever found within Denver city limits. BestReviews is reader-supported and may earn an affiliate commission. Amazon Prime Day Deals 'This fossil comes from an era just before the mass extinction that wiped out the dinosaurs, and it offers a rare window into the ecosystem that once existed right beneath modern-day Denver,' Hagadorn said. The fossil bone has been identified as a vertebrae of an herbivorous dinosaur, according to the museum, which said the bone occurs in Late Cretaceous rocks that are dated to approximately 67.5 million years ago. Patrick O'Connor, director of Earth & Space Science at the DMNS, was part of the team that identified the bone and said it may be 'the most unusual dinosaur discovery' he had ever been a part of. 'Not only is it exceptionally rare to find any fossil as part of a drilling project, but the discovery provided an outstanding collaborative opportunity for the Museum earth sciences team to produce an article,' O'Connor said. That article, 'Denver's deepest dinosaur,' was published in the scientific journal Rocky Mountain Geology in June. The research was led by DMNS postdoctoral scholar Dr. Holger Petermann. 'This fossil underscores the highly fossiliferous nature of the entire D1 Sequence (Denver Formation) and increases the diversity of dinosaurs known from the Denver metropolitan area,' reads an excerpt from the article's abstract. The fossil bone is now currently on display at the DMNS in its 'Discovering Teen Rex' exhibition.